Pareidolias and cognition in isolated REM sleep behavior disorder.


Journal

Parkinsonism & related disorders
ISSN: 1873-5126
Titre abrégé: Parkinsonism Relat Disord
Pays: England
ID NLM: 9513583

Informations de publication

Date de publication:
06 2020
Historique:
received: 05 02 2020
revised: 23 04 2020
accepted: 14 05 2020
pubmed: 4 6 2020
medline: 23 6 2021
entrez: 4 6 2020
Statut: ppublish

Résumé

Though visual illusions and hallucinations are common in dementia with Lewy bodies (DLB) and Parkinson's disease (PD), they are not typically observed clinically in prodromal stages, including isolated REM sleep behavior disorder (iRBD). False-noise errors on the pareidolia test (seeing faces when none are present) may be an effective measure of susceptibility to future hallucinations in iRBD. One hundred patients with iRBD underwent the 20-image pareidolia test. Clinical markers were assessed and a neuropsychological battery was administered. An exploratory analysis on the impact of pareidolic errors on phenoconversion was also performed. In our cohort, 17 patients (17%) made false-noise pareidolic errors. These patients had significantly lower total Montreal Cognitive Assesment (MoCA) scores (26.7 ± 2.3 vs. 24.4 ± 2.6, B = -1.88, 95% CI: [-3.17, -0.59]), with lower subcomponent MoCA scores on memory and visuospatial-executive sections. Pareidolic errors were also associated with lower visuospatial, attention/executive, and memory scores on the neuropsychological tests. Furthermore, after 1.6 years follow-up, 3/16 (19%) patients making pareidolic errors had phenoconverted at time of publication compared to 6/71 (8%) patients who did not make errors. Pareidolic errors in patients with iRBD are associated with poorer overall cognition and may indicate higher risk of DLB.

Sections du résumé

BACKGROUND
Though visual illusions and hallucinations are common in dementia with Lewy bodies (DLB) and Parkinson's disease (PD), they are not typically observed clinically in prodromal stages, including isolated REM sleep behavior disorder (iRBD). False-noise errors on the pareidolia test (seeing faces when none are present) may be an effective measure of susceptibility to future hallucinations in iRBD.
METHODS
One hundred patients with iRBD underwent the 20-image pareidolia test. Clinical markers were assessed and a neuropsychological battery was administered. An exploratory analysis on the impact of pareidolic errors on phenoconversion was also performed.
RESULTS
In our cohort, 17 patients (17%) made false-noise pareidolic errors. These patients had significantly lower total Montreal Cognitive Assesment (MoCA) scores (26.7 ± 2.3 vs. 24.4 ± 2.6, B = -1.88, 95% CI: [-3.17, -0.59]), with lower subcomponent MoCA scores on memory and visuospatial-executive sections. Pareidolic errors were also associated with lower visuospatial, attention/executive, and memory scores on the neuropsychological tests. Furthermore, after 1.6 years follow-up, 3/16 (19%) patients making pareidolic errors had phenoconverted at time of publication compared to 6/71 (8%) patients who did not make errors.
CONCLUSION
Pareidolic errors in patients with iRBD are associated with poorer overall cognition and may indicate higher risk of DLB.

Identifiants

pubmed: 32492550
pii: S1353-8020(20)30126-7
doi: 10.1016/j.parkreldis.2020.05.017
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

76-79

Subventions

Organisme : CIHR
ID : 286641
Pays : Canada

Informations de copyright

Copyright © 2020. Published by Elsevier Ltd.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors have no financial disclosures in relationship to this manuscript.

Auteurs

Lucy Honeycutt (L)

Department of Neurology, McGill University, Montreal General Hospital, Montreal, Canada.

Jean-François Gagnon (JF)

Centre d'Études Avancées en Médecine du Sommeil, CIUSSS-NÎM-Hôpital du Sacré-Cœur de Montréal, Montreal, QC, Canada; Department of Psychology, Université du Québec à Montréal, Montreal, Quebec, Canada.

Amélie Pelletier (A)

Centre d'Études Avancées en Médecine du Sommeil, CIUSSS-NÎM-Hôpital du Sacré-Cœur de Montréal, Montreal, QC, Canada; Department of Neurology, The Research Institute of the McGill University Health Centre, Montreal, Canada.

Jessie De Roy (J)

Centre d'Études Avancées en Médecine du Sommeil, CIUSSS-NÎM-Hôpital du Sacré-Cœur de Montréal, Montreal, QC, Canada; Department of Psychology, Université du Québec à Montréal, Montreal, Quebec, Canada.

Jacques Y Montplaisir (JY)

Centre d'Études Avancées en Médecine du Sommeil, CIUSSS-NÎM-Hôpital du Sacré-Cœur de Montréal, Montreal, QC, Canada; Department of Psychiatry, Université de Montréal, Montreal, QC, Canada.

Ronald B Postuma (RB)

Department of Neurology, McGill University, Montreal General Hospital, Montreal, Canada; Centre d'Études Avancées en Médecine du Sommeil, CIUSSS-NÎM-Hôpital du Sacré-Cœur de Montréal, Montreal, QC, Canada; Department of Neurology, The Research Institute of the McGill University Health Centre, Montreal, Canada. Electronic address: ron.postuma@mcgill.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH